To withdraw nondiscriminatory treatment (normal trade relations treatment) from the People's Republic of China.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
55pct
15d open
vs 5,767 other HR bills in the 107th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2001 · year_end · Trade (domestic/foreign)
H.R. 3005, H. Res. 306 - "Bipartisan Trade Promotion Authority Act of 2001" Legislation to extend trade authorities procedures with respect to reciprocal trade agreements. H.R. 1467 - "To withdraw nondiscriminatory treatment (normal trade relations treatment) from the People's Republic of China" Legislation to withdraw nondiscriminatory treatment (normal trade relations treatment) from the People's Republic of China. H.R. 2149 - "Trade Promotion Authority Act of 2002" Legislation to extend trade authorities procedures with respect to reciprocal trade agreements. S. 599 - "Permanent Trade Promotion Authority and Market Access Act of 2001" Legislation to amend the Omnibus Trade and Competitiveness Act of 1988 to establish permanent trade negotiating and trade agreemetn implementing authority. Trade agreements involving Japanense market access for medical devices made by U.S. based corporation.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2001 · mid_year · Trade (domestic/foreign)
Accession of China into the WTO with specific interest in quotas, licensing, tariffs and distribution rights. NTR for China. Tariff and non-tariff barriers to fertilizer imports to the E.U. WTO treatment of Foreign Sales Corporations (FSCs). H.R.1467, To withdraw nondiscriminatory treatment from the People's Republic of China. H.R.1497, To revoke the authority to extend permanent normal trade relations to the People's Republic of China. H.J.Res.50, Disapproving the extension of the waiver authority...to the People's Republic of China. The President's Trade Promotion Authority. S.599, Permanent Trade Promotion Authority and Market Access Act of 2001. H.R. 2149, The Trade Promotion Authority Act. Fertilizer exports to India and subsidy issues.
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Labor, Dept of (DOL), Mine Safety & Health Administration (MSHA), Occupational Safety & Health Administration (OSHA), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2001 · mid_year · Trade (domestic/foreign)
H.R. 1467 - Resolution to withdraw normal trade relations treatment from the People's Republic of China. H.R. 2149 _"Trade Promotion Authority Act of 2001" To extend trade authorities procedures with respect to reciprocal trade agreements. S. 599 - "Permanent Trade Promotion Authority and Market Access Act of 2001" Legislation to amend the Omnibus Trade and Competitiveness Act of 1988 to establish permanent trade negotiating and trade agreement implementing authority. Implementation of trade agreements involving Japanese market access for medical devices made by U.S. based corporations.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)